Atherosclerosis
Volume 212, Issue 2 , Page 704, October 2010

Corrigendum to “Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia” [Atherosclerosis 210 (2010) 202–208]

  • Leiv Ose

      Affiliations

    • Lipid Clinic, Rikshospitalet, Oslo University Hospital, Oslo N-0027, Norway
    • Corresponding Author InformationCorresponding author. Tel.: +47 23075614; fax: +47 23075610.
  • ,
  • Dragos Budinski

      Affiliations

    • Kowa Research Europe Ltd., 105 Wharfedale Road, Winnersh Triangle, Wokingham, Berkshire RG41 5RB, United Kingdom
  • ,
  • Neil Hounslow

      Affiliations

    • Kowa Research Europe Ltd., 105 Wharfedale Road, Winnersh Triangle, Wokingham, Berkshire RG41 5RB, United Kingdom
  • ,
  • Valerie Arneson

      Affiliations

    • PharmaNet Ltd., Buckingham Court, Kingsmead Business Park, London Road, High Wycombe, HP11 1JU, United Kingdom

published online 23 August 2010.

Article Outline

 

The author(s) regret that the following errors occurred in the original paper.

The author(s) would like to apologise for any inconvenience this may have caused to the readers of the journal.

(1)Page 3: Title for table 1 should read ‘Number of patients who attained LDL-C targets (efficacy population)’.

(2)Page 3: Right hand column, line 4 (para below table 1) should be: ‘The supernatant is analyzed for HDL-C, by enzyme’.

(3)Page 4: In the footer it should say: ‘d=Oxidised LDL was measured in only one double-blind study’, i.e. there should be an ‘=’ sign like the lines above it.

(4)Page 4: The figures do not line up in the bottom part of the table, with those at the upper part of the table. At the bottom of the table there should be a ‘Nb’ in the bottom section where HsCRP is referred to, directly in line with the Nb at the top of the table. The text saying ‘Median change from baseline’ needs to be moved to the right hand side, directly in line with the ‘Mean percent change (SD)c’ at the top of the table.

PII: S0021-9150(10)00401-6

doi:10.1016/j.atherosclerosis.2010.05.023

Refers to article:

  • Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia , 18 January 2010

    Leiv Ose, Dragos Budinski, Neil Hounslow, Valerie Arneson
    Atherosclerosis May 2010 (Vol. 210, Issue 1, Pages 202-208)

Atherosclerosis
Volume 212, Issue 2 , Page 704, October 2010